The test that reveals cancer sooner

MorNuCo Laboratories’ clinical trial, recently published in Clinical Proteomics, demonstrated the ability of a serum test to detect the presence of mesothelioma 4-10 years in advance of clinical symptoms. The ONCOblot® Test detects ENOX2 proteins present in serum, and in this trial, ENOX2 proteins that are specific to mesothelioma. This is an exciting step forward in the continued development of tools for early cancer detection. —> Read More